Hyperion raises $60M to battle urea cycle disorders | VentureBeat
DEALS.VENTUREBEAT.COM - Hyperion Therapeutics, developer of treatments for urea cycle disorders and illnesses, has brought in $60 million in a third round of financing from Bay City Capital, Panorama Capital, Highland Capital Partners, New Enterprise Associates and Sofinnova Ventures.Based in South San Francisco, the company recently completed phase two clinical trials for its lead drug candidate, and says the new...
First tweeted by RSS_VentureBeat.
From the Front Page
Socialsafe.net
- Comments
- Tweets (10)
Tweets
Sorry there have been no tweets in the last 7 days.
